Purpose: To identify the specific intratumoral and microenvironmental heterogeneity of acral melanoma (AM) and mucosal melanoma (MM), we aimed to delineate their distinct cellular compositions, evolutionary trajectories, and subtype-specific therapeutic strategies. Experimental Design: Single-cell transcriptomic and genomic landscapes were analyzed across 42 melanoma (28 AM, 11 MM, and 3 nonacral cutaneous melanoma) samples, supplemented by in vitro and in vivo validation. Tumor and stromal cells were profiled using single-cell RNA sequencing, whole-exome sequencing, and functional assays, including transwell migration, co-culture systems, and xenograft models. Results: Tumor cells exhibited divergent evolutionary routes, with MM dominated by MGP+/PCOLCE+ subpopulations showing high epithelial-to-mesenchymal transition potential. MM displayed elevated neutrophil infiltration and CXCL3+ tumor-associated macrophages, whereas AM was enriched with PI16+ cancer-associated fibroblasts promoting tumor proliferation. Molecular classification revealed MM subtypes: an antigen-presenting subtype linked to favorable outcomes and a proliferative subtype associated with recurrence. TIGIT+ regulatory T cells were enriched in AM, suggesting targeted inhibition potential. Genomic analysis connected BRAF/NRAS mutations to ALDOA+ stem-like tumor cells and identified prostaglandin D2 synthetase as a therapeutic target in triple–wild-type/melanomas. Conclusions: Our study provides a comprehensive comparison of AM and MM, uncovering subtype-specific stromal–immune interactions and molecular programs. The findings highlight actionable targets (e.g., TIGIT in AM and CXCL3+ macrophages in MM) and propose a framework for precision therapies, biomarker-driven trials, and risk stratification to improve outcomes in these aggressive melanomas.
10 December 2025 in Anesthesiology and Perioperative Science
Purpose: Many observational studies have revealed intriguing connections between multisite chronic pain (MCP) and psychiatric disorders. Yet, the critical question of causality remains elusive. Our aim was to systematically evaluate the causal relationships between MCP and 11 psychiatric disorder subtypes while identifying potential mediators. Methods: We adopted a three-stage two-sample bi-directional Mendelian randomization (MR) analysis to ensure the robustness and reliability of our findings. MCP summary data was sourced from a genome-wide association study with 387,649 individuals in the UK Biobank. The discovery stage used summary statistics mainly from the Psychiatric Genomics Consortium, while validation involved MR analysis with data from the FinnGen consortium. Meta-analysis was conducted to pool MR estimates from the discovery and validation stages. Results: Positive causal relationships were found between MCP and 7 psychiatric disorder subtypes, including depression, panic disorder, anxiety disorders, insomnia, attention deficit hyperactivity disorder, post-traumatic stress disorder, and bipolar disorder, with combined odds ratios ranging from 1.361 ( P < 0.00001) to 3.322 ( P < 0.0045). Reverse MR revealed bidirectional causal associations between depression and MCP, along with anxiety disorders and MCP ( P < 0.05). Additionally, causal links were identified between MCP and smoking initiation, physical activity, body mass index, and changes in human blood cells. Multivariable MR analysis indicated these factors may mediate the relationship between MCP and psychiatric disorders. Conclusion: Our findings provide novel insights into the involvement of MCP in psychiatric disorders, highlighting potential modifiable risk factors to reduce their incidence.